EPISODE · Feb 6, 2021 · 22 MIN
The Race To Vaccinate: Dr. Atul Gawande Provides Perspective
from GZERO World with Ian Bremmer · host GZERO Media
Can the United States vaccinate enough of its population to prevent hundreds of thousands of deaths before new and more contagious COVID-19 variants take hold? And will these vaccines even be effective against more adaptable mutations of the virus? Surgeon and public health expert Dr. Atul Gawande, most recently of the Biden/Harris COVID-19 Transition Task Force, joins the podcast to discuss the latest in the global effort to vaccinate our way out of this pandemic. He also explains why people should get the Johnson & Johnson vaccine if offered the chance, despite its lower overall efficacy rate compared to the mRNA-based vaccines from Pfizer and Moderna. Subscribe to the GZERO World with Ian Bremmer Podcast on Apple Podcasts, Spotify, or your preferred podcast platform, to receive new episodes as soon as they're published. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Embed this episode
What this episode covers
Can the United States vaccinate enough of its population to prevent hundreds of thousands of deaths before new and more contagious COVID-19 variants take hold? And will these vaccines even be effective against more adaptable mutations of the virus? Surgeon and public health expert Dr. Atul Gawande, most recently of the Biden/Harris COVID-19 Transition Task Force, joins the podcast to discuss the latest in the global effort to vaccinate our way out of this pandemic. He also explains why people should get the Johnson & Johnson vaccine if offered the chance, despite its lower overall efficacy rate compared to the mRNA-based vaccines from Pfizer and Moderna.
NOW PLAYING
The Race To Vaccinate: Dr. Atul Gawande Provides Perspective
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.